Literature DB >> 10699190

Maternal and fetal serum nitric oxide (NO) concentrations in normal pregnancy, pre-eclampsia and eclampsia.

A H Shaamash1, E D Elsnosy, A M Makhlouf, M M Zakhari, O A Ibrahim, H M EL-dien.   

Abstract

OBJECTIVES: To measure the maternal and fetal serum concentrations of total nitrites and nitrates (as an index of nitric oxide production) in normal pregnancy, pre-eclampsia and eclampsia.
DESIGN: Three groups of women were studied cross-sectionally: late pregnant women with pre-eclampsia and eclampsia (n=31); normal late pregnant women (n=32); and age-matched healthy non-pregnant women (n=21). Venous blood samples were collected from all women and both maternal and umbilical venous samples were collected from pregnant women.
METHODS: Blood samples were assayed for nitric oxide (NO) production by Greiss reaction which measures the combined oxidation products of NO (total nitrites and nitrates).
RESULTS: There was a significant increase in serum total nitrites and nitrates concentrations in normal pregnant women than in the serum of age-matched normal non-pregnant women (P<0.0001). Significantly higher total nitrites and nitrates levels were found in the maternal sera of the pre-eclamptic and eclamptic women compared with those of normal pregnant women (P<0.0001). Also, fetal blood levels of total nitrites and nitrates were significantly increased in pre-eclampsia and eclampsia compared with those of normal pregnancy (P<0.0001).
CONCLUSIONS: (1) Serum nitric oxide (NO) production is increased in normal pregnancy than in the normal non-pregnancy. (2) Maternal and fetal serum NO levels are increased significantly in pre-eclampsia and eclampsia, which possibly represents a compensatory/protective mechanism to maintain blood flow and limit platelets aggregation in the fetal-maternal circulations. (3) The increase in NO production is directly related to the severity of pre-eclampsia; this would be of diagnostic significance for the prediction of the severity of this syndrome.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10699190     DOI: 10.1016/s0020-7292(99)00213-1

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  24 in total

1.  Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia.

Authors:  B Lamarca
Journal:  Minerva Ginecol       Date:  2012-08

Review 2.  Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia.

Authors:  Babbette D LaMarca; Jeffery Gilbert; Joey P Granger
Journal:  Hypertension       Date:  2008-02-07       Impact factor: 10.190

3.  Continued Investigation Into 17-OHPC: Results From the Preclinical RUPP Rat Model of Preeclampsia.

Authors:  Lorena M Amaral; Jessica L Faulkner; Jamil Elfarra; Denise C Cornelius; Mark W Cunningham; Tarek Ibrahim; Venkata Ramana Vaka; Jessica McKenzie; Babbette LaMarca
Journal:  Hypertension       Date:  2017-10-30       Impact factor: 10.190

4.  Analysis of nitroso-proteomes in normotensive and severe preeclamptic human placentas.

Authors:  Hong-hai Zhang; Yu-ping Wang; Dong-bao Chen
Journal:  Biol Reprod       Date:  2011-01-12       Impact factor: 4.285

Review 5.  Phosphodiesterase Inhibition in the Treatment of Preeclampsia: What Is New?

Authors:  Anne Brandolt Larré; Fernando Sontag; Débora Montenegro Pasin; Nathália Paludo; Rayssa Ruszkowski do Amaral; Bartira Ercília Pinheiro da Costa; Carlos Eduardo Poli-de-Figueiredo
Journal:  Curr Hypertens Rep       Date:  2018-07-26       Impact factor: 5.369

Review 6.  PPAR-γ -- a possible drug target for complicated pregnancies.

Authors:  Fergus P McCarthy; Aoife C Delany; Louise C Kenny; Sarah K Walsh
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

Review 7.  Pathophysiology of pre-eclampsia: update on the role of nitric oxide.

Authors:  Maki Kashiwagi; Roland Zimmermann; Ernst Beinder
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

8.  NF-κB-responsive miRNA-31-5p elicits endothelial dysfunction associated with preeclampsia via down-regulation of endothelial nitric-oxide synthase.

Authors:  Suji Kim; Kyu-Sun Lee; Seunghwan Choi; Joohwan Kim; Dong-Keon Lee; Minsik Park; Wonjin Park; Tae-Hoon Kim; Jong Yun Hwang; Moo-Ho Won; Hansoo Lee; Sungwoo Ryoo; Kwon-Soo Ha; Young-Guen Kwon; Young-Myeong Kim
Journal:  J Biol Chem       Date:  2018-10-02       Impact factor: 5.157

9.  Sodium hydrosulfide prevents hypertension and increases in vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 in hypertensive pregnant rats.

Authors:  Jose Sergio Possomato-Vieira; Victor Hugo Gonçalves-Rizzi; Tamiris Uracs Sales Graça; Regina Aparecida Nascimento; Carlos A Dias-Junior
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-09-12       Impact factor: 3.000

10.  Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia.

Authors:  J S Possomato-Vieira; R A Khalil
Journal:  Adv Pharmacol       Date:  2016-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.